Jump Financial, LLC Harvard Bioscience Inc Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$4.19 - $6.16 $256,381 - $376,924	61,189 New	61,189 $335,000
Q2 2023 Aug 07, 2023	BUY	$4.19 - $6.16 $256,381 - $376,924	61,189 New	61,189 $335,000
Q2 2022 Aug 09, 2022	BUY	$3.28 - $6.42 $129,231 - $252,948	39,400 New	39,400 $142,000
Q3 2021 Nov 12, 2021	SELL	$6.98 - $8.47 $148,674 - $180,411	-21,300 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.44 - $8.4 $34,816 - $53,760	6,400 Added 42.95%	21,300 $177,000
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $58,259 - $104,151	14,900 New	14,900 $81,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.